Dissecting Structural Details of Hepadnavirus Subviral Particles
剖析嗜肝DNA病毒亚病毒颗粒的结构细节
基本信息
- 批准号:10407642
- 负责人:
- 金额:$ 20.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-19 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:Animal ExperimentationAntibodiesArchitectureB-LymphocytesBiological ModelsCapsidCell LineCell physiologyCellsChronic Hepatitis BClinical TrialsCryo-electron tomographyCryoelectron MicroscopyDiseaseElectron MicroscopeEndoplasmic ReticulumEpitopesExperimental ModelsFilamentFoundationsFutureGenomeGoalsGolgi ApparatusHepadnaviridaeHepatitis BHepatitis B InfectionHepatitis B Surface AntigensHepatitis B VirusHumanImmuneImmune EvasionImmune responseIntegral Membrane ProteinLabelLeadLearningMalaria VaccinesMasksMedicalMembraneMembrane BiologyMembrane LipidsModelingMorphogenesisMorphologyN-terminalNatural ImmunityPathogenesisPathway interactionsPatientsPersonsPharmaceutical PreparationsProteinsPublic HealthReportingResolutionRoleSerumStructureStudy modelsSurface AntigensSystemT-LymphocyteTestingTimeVaccinesViralVirionVirus DiseasesWoodchuckWoodchuck Hepatitis B Virusanti-hepatitis Bbaseclinically relevantdrug testinghepatoma cellinsightneutralizing antibodynovel therapeutic interventionparticlepre-clinicalpreclinical evaluationpreventserological marker
项目摘要
Hepatitis B virus (HBV) infection is a global public health concern; however, current approval therapies rarely lead to a complete cure. Hepatitis B surface antigen (HBsAg) is the serological marker for HBV infection. It is characterized by three transmembrane proteins having the same C-termini with variable in-frame extension at the N-terminal ends. Naturally, HBsAg proteins are incorporated in the viral envelope or assembled into genome-free and capsid-free subviral particles (SVPs) with the lipid membrane derived from the host cells. Recently, a new therapeutic approach by blocking assembly and release of SVPs has shown promising results in rapidly reducing HBsAg level in chronic HBV- infected patients. Despite its potential clinically relevant applications, there is no structural information available for HBsAg and yet different models of SVPs have been proposed. In this proposal we focus on obtaining the high resolution structures of SVPs from different model systems using cryo-electron microscope (cryo-EM). We will test the central hypothesis that changes in the structural organizations of SVPs will have important implications on their secretion pathway. In Aim 1, we will determine the structures of SVP from woodchuck hepatitis virus (WHV). Woodchuck infected with WHV is a critical experimental model for studying pathogenesis of HBV infection. In Aim 2, we will elucidate the structural details of HBV SVP from carrier's sera and hepatoma cell line. We will use antibodies to spatially label different regions of HBsAg. Finally, all structures determined from this proposal will be compared and used to build a complete picture of SVP with the detailed structural information of Hepadnavirus surface antigen. Successful completion of the proposed project will reveal new structural information of SVPs and will deepen our understanding of HBV particles morphogenesis to facilitate current efforts in finding a cure for HBV infection.
B型肝炎病毒(HBV)感染是一个全球性的公共卫生问题;然而,目前批准的治疗很少导致完全治愈。B型肝炎表面抗原(HBsAg)是HBV感染的血清学标志物。其特征在于三个跨膜蛋白具有相同的C-末端,在N-末端具有可变的框内延伸。自然地,HBsAg蛋白被掺入病毒包膜中或与来自宿主细胞的脂质膜组装成无基因组和无衣壳的亚病毒颗粒(SVP)。最近,通过阻断SVP的组装和释放的新的治疗方法在快速降低慢性HBV感染患者中的HBsAg水平方面显示出有希望的结果。尽管其潜在的临床相关的应用,有没有结构信息可用于HBsAg,但已提出不同的模型SVP。在这个建议中,我们专注于获得高分辨率的结构的SVPs从不同的模型系统使用冷冻电子显微镜(cryo-EM)。我们将测试中心的假设,即结构组织的变化的SVP将有重要的影响,他们的分泌途径。目的1:确定土拨鼠肝炎病毒(WHV)SVP的结构。WHV感染土拨鼠是研究HBV感染机制的重要实验模型。目的二,我们将从携带者血清和肝癌细胞系中阐明HBV SVP的结构细节。我们将使用抗体来空间标记HBsAg的不同区域。最后,将比较从该提议确定的所有结构,并使用嗜肝DNA病毒表面抗原的详细结构信息构建SVP的完整图片。该项目的成功完成将揭示SVP的新结构信息,并将加深我们对HBV颗粒形态发生的理解,以促进目前寻找HBV感染治愈方法的努力。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Protein Structure Predictions, Atomic Model Building, and Validation Using a Cryo-EM Density Map from Hepatitis B Virus Spherical Subviral Particle.
- DOI:10.21769/bioprotoc.4751
- 发表时间:2023-07-20
- 期刊:
- 影响因子:0.8
- 作者:
- 通讯作者:
Cryo-EM structures of human hepatitis B and woodchuck hepatitis virus small spherical subviral particles.
- DOI:10.1126/sciadv.abo4184
- 发表时间:2022-08-05
- 期刊:
- 影响因子:13.6
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Che-Yen Wang其他文献
Che-Yen Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Che-Yen Wang', 18)}}的其他基金
Structural characterization of native HBV capsids and virions from human cells
人类细胞天然 HBV 衣壳和病毒颗粒的结构表征
- 批准号:
10736669 - 财政年份:2023
- 资助金额:
$ 20.27万 - 项目类别:
Dissecting Structural Details of Hepadnavirus Subviral Particles
剖析嗜肝DNA病毒亚病毒颗粒的结构细节
- 批准号:
10287141 - 财政年份:2021
- 资助金额:
$ 20.27万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 20.27万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 20.27万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 20.27万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 20.27万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 20.27万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 20.27万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 20.27万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 20.27万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 20.27万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 20.27万 - 项目类别: